scholarly article | Q13442814 |
P2093 | author name string | Jong-Wook Lee | |
Sun Hee Park | |||
Chun-Choo Kim | |||
Dong-Gun Lee | |||
Jin-Hong Yoo | |||
Jung-Hyun Choi | |||
Wan-Shik Shin | |||
Woo-Sung Min | |||
Yonggoo Kim | |||
Su-Mi Choi | |||
Kyungja Han | |||
Jihyang Lim | |||
P2860 | cites work | CMV monitoring using blood cells and plasma: a comparison of apples with oranges? | Q54558030 |
The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients. | Q54563527 | ||
Quantitative analysis of cytomegalovirus load using a real-time PCR assay. | Q64953713 | ||
Evaluation of the CMV-vue antigenemia assay for rapid detection of cytomegalovirus in peripheral blood leukocytes | Q72794001 | ||
Cytomegalovirus quantification in plasma by an automated real-time PCR assay | Q79828069 | ||
Validation of a DNAemia cutoff for preemptive therapy of cytomegalovirus infection in adult hematopoietic stem cell transplant recipients | Q80525527 | ||
Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes | Q31835044 | ||
Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation | Q33968089 | ||
Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. | Q33974273 | ||
Molecular methods for cytomegalovirus surveillance in bone marrow transplant recipients | Q34439235 | ||
Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma | Q34991529 | ||
Automated extraction and quantification of human cytomegalovirus DNA in whole blood by real-time PCR assay | Q35638781 | ||
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. | Q36597473 | ||
Quantitation of cytomegalovirus: methodologic aspects and clinical applications. | Q39468915 | ||
Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients | Q39626863 | ||
Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients | Q39732759 | ||
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia | Q40186252 | ||
Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients | Q40507092 | ||
Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection | Q40762485 | ||
Analytic validation of a quantitative real-time PCR assay to measure CMV viral load in whole blood | Q43590471 | ||
The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease | Q43940394 | ||
Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation | Q44214552 | ||
Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia | Q44618517 | ||
In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients | Q44669550 | ||
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea | Q45271053 | ||
Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients | Q46801387 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | stem cell transplantation | Q65592366 |
Cytomegalovirus | Q6946 | ||
whole blood | Q7997549 | ||
P304 | page(s) | 571-578 | |
P577 | publication date | 2009-07-29 | |
P1433 | published in | Journal of Korean Medical Science | Q24039955 |
P1476 | title | Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients | |
P478 | volume | 24 |
Q44535281 | Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation |
Q41041259 | Clinical Utility of Viral Load in the Management of Cytomegalovirus Infection in Solid Organ Transplant Patients in Kuwait |
Q87765255 | Comparable outcomes between younger (⩽40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning |
Q41566881 | Comparison of quantitation of cytomegalovirus DNA by real-time PCR in whole blood with the cytomegalovirus antigenemia assay. |
Q36288594 | Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients |
Q42275611 | Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients |
Q43735414 | Cytomegalovirus infection in pediatric allogenic hematopoietic stem cell transplantation. A single center experience. |
Q33889365 | Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies |
Q40655846 | Effects of Granulocyte and Monocyte Adsorptive Apheresis in Renal Transplantation Recipients With Concomitant Cytomegalovirus Infection. |
Q102075443 | Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children |
Q53132522 | Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy. |
Q37086251 | Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission |
Q52728829 | Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. |
Q41092916 | Long-term clinical outcomes of hematopoietic cell transplantation for intermediate-to-poor-risk acute myeloid leukemia during first remission according to available donor types |
Q41373726 | Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources. |
Q38694426 | Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia |
Q42977950 | Preemptive therapy for cytomegalovirus based on real-time measurement of viral load in liver transplant recipients |
Q37763611 | Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus |
Q92741448 | Relationship of Circulating Cytomegalovirus Levels Obtained Through Antigenemia Testing and Quantitative PCR Differs Between Children and Adults |
Q35226610 | SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation |
Q51753093 | Similar outcomes of peripheral blood stem cells vs. bone marrow for human leukocyte antigen-matched unrelated donor transplantation in adult patients with acute myeloid leukemia using risk-adapted graft-versus-host disease prophylaxis. |
Q33591729 | Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. |